Messaging Strategies for Lung Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
To evaluate the real-world effectiveness and implementation strategies for mPATH-Lung, investigators propose a pragmatic, randomized controlled trial across an academic Learning Health System. The trial will contrast several approaches to participant outreach and will specifically target engaging fully powered cohorts of racial/ethnic minorities and rural residents.
Who Is on the Research Team?
Brent Heideman, Jr., MD
Principal Investigator
Wake Forest Baptist Comprehensive Cancer Center
Are You a Good Fit for This Trial?
This trial is for people aged 50-77 who have smoked the equivalent of a pack a day for 20 years, are current smokers or quit within the last 15 years. They must be patients within the Atrium Health Wake Forest Baptist network with at least one recent primary care visit and have either a patient portal account or cellphone number on record.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive outreach through mPATH-Lung to increase lung cancer screening rates
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Portal message only
- Portal Message with Reminder Text Messages
- Text Message with Reminder Text Messages
Trial Overview
The study tests different methods of reaching out to lung cancer patients using technology: text messages with reminders, portal messages with reminders, and portal messages only. It aims to see which method is most effective in engaging diverse groups including minorities and rural residents.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Active Control
Patient portal message first followed by up to 3 reminder text messages.
Text message only with up to 3 reminder text messages.
Portal message only with no reminder messages.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.